BridgeBio Pharma (BBIO) Prepaid Assets (2018 - 2026)

BridgeBio Pharma's Prepaid Assets history runs 9 years deep, the most recent figure standing at $62.9 million for Q1 2026.

• In Q1 2026, Prepaid Assets rose 77.95% year-over-year to $62.9 million; the TTM figure through Mar 2026 stood at $62.9 million (up 77.95% YoY), while the FY2025 annual figure was $44.1 million, up 26.39% from the prior year.
• Prepaid Assets came in at $62.9 million for Q1 2026 at BridgeBio Pharma, up from $44.1 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $62.9 million in Q1 2026 to a low of $20.5 million in Q2 2023.
• A 5-year average of $34.8 million and a median of $32.8 million in 2022 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets sank 37.27% in 2023 and soared 112.14% in 2025, its largest moves.
• BridgeBio Pharma's Prepaid Assets stood at $21.9 million in 2022, then increased by 10.87% to $24.3 million in 2023, then surged by 43.46% to $34.9 million in 2024, then climbed by 26.39% to $44.1 million in 2025, then surged by 42.76% to $62.9 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $62.9 million, $44.1 million, and $52.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison